The mitochondrial unfolded protein response (UPRmt) is a surveillance pathway induced by diverse stressors including reactive oxygen species, respiratory chain deficits, and mitochondrial DNA damage. Its activation helps to restore proteostasis and to protect against stresses caused by statin toxicity and bacterial infection. The transcription factor ATFS-1 is required for UPRmt signaling and the balance between ATFS-1 trafficking to the mitochondria and the nucleus regulates its signaling output. Consistent with a central role for mitochondria in mammalian ischemia-reperfusion injury, we found that either pharmacological or genetic activation of the UPRmt was sufficient to protect worms from anoxic death and cell damage. We found that
atfs-1 was necessary for this protection and that in the absence of
atfs-1, mitochondrial stress exacerbated anoxic death. In contrast, a gain-of-function (gf) mutation in
atfs-1 was endogenously protected against anoxia. We then created a genetic model to study the cell specific effects of
atfs-1. Our model utilizes a FLP-FRT-wCherry promoter interruption of an
atfs-1 single copy MosSCI transgene to restrict the expression of either the wild type or gf allele to specific cells. Expression in this model via the native promoter at physiological levels is expected to more closely recapitulate endogenous regulatory mechanisms. Since mitochondrial stress has been suggested to result in non-cell autonomous signaling, we were motivated to use our model to determine whether the UPRmt could also protect cells from anoxic damage through similar mechanisms. We tested whether selective expression of
atfs-1 was sufficient to activate the UPRmt in specific tissues and whether this elicited global adaptation to anoxia. In addition to allowing us to rigorously define the role of
atfs-1 in regulating anoxic sensitivity, this model will be useful in studying how UPRmt influences other cellular and systems outputs.